About
Regeneration after Cerebral Stroke
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
33
By Phase
PHASE1: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06817577Lead Sponsor
NG004 in Spinal Cord Injury Patients
PHASE1Recruiting
21 participants
Started: Dec 18, 2024 · Completed: Sep 30, 2026
NCT06671236Lead Sponsor
Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases
PHASE1Recruiting
12 participants
Started: Nov 21, 2024 · Completed: Dec 31, 2027
Locations (1)
Headquarters
Zurich, Switzerland
Map
Loading map...